Luminal glucose enhances transepithelial Na+ and fluid transports in rat lungs

Glucose transporter/T1R3-expressing cells in rat tracheal epithelium

Glucose transport plays an important role in maintaining low sugar concentration in airway surface liquid (ASL), which is critical for mucociliary clearance and bacterial colonization. Experimental evidence indicates that glucose/hexose uptake in lung/airway cells occurs by means of two structurally distinct glucose transporter pathways: the Na(+) -dependent glucose transporters (SGLT family) and the facilitative glucose transporters (GLUT family). In this study, we examined the expression of the major glucose transporters of the intestine, GLUT2, GLUT5, SGLT1 and T1R3 taste receptor subunit, in the trachea of rats using immunohistochemistry and immunoelectron microscopy, and compared them using double-labeled confocal microscopy. We found that GLUT2, GLUT5, SGLT1 and T1R3 are selectively expressed in different cell types. T1R3 and GLUT2 are predominantly expressed in subsets of solitary chemoreceptor cells (SCCs) and ciliated cells, GLUT5 is present in subsets of SCCs and in secretory cells, and SGLT1 is exclusively expressed in a unique cell type, SCCs. Furthermore, we demonstrated that T1R3 is colocalized with SGLT1 in SCCs and with GLUT2 transporter in ciliated cells. In conclusion, these findings reveal that different cell types are associated with the uptake of glucose in ASL and that, due to their T1R3 expression, SCCs and ciliated cells are most likely to participate in the chemosensory process in ASL.

Glucose transport in the lung and its role in liquid movement

Glucose concentration in the liquid present in the alveolar/airway lumen is the consequence of the balance between removal by lung epithelial cells and entry from the plasma or lung interstitium through the paracellular pathway. Glucose removal is mediated by active, Na(+) -dependent, cotransport and results in transepithelial Na(+) transport and liquid absorption in animals with significant rates of luminal glucose uptake and when luminal glucose concentration is high enough. Cotransport kinetics predicted a low luminal glucose concentration at the steady state, and foetal lung fluid and adult alveolar epithelial lining fluid glucose concentrations were indeed found lower than plasma. When luminal glucose concentration is low, the glucose-dependent part of transepithelial Na(+) transport is abated and alveolar liquid clearance reduced. A means to refuel this mechanism of liquid absorption would be to increase glucose entry in alveolar spaces through an increase in paracellular permeability. This hypothesis was modelled, and experimental data were found to acceptably agree with predictions.

Sodium-coupled transport of glucose by plasma membranes of type II pneumocytes

Sodium-dependent absorption of alveolar fluid promotes efficient gas exchange. In animal models, alveolar glucose stimulates phlorizin-sensitive, Na(+)-dependent fluid absorption. It is hypothesized that Na+/glucose cotransporters are localized to apical membranes of type II pneumocytes. Enriched apical and basolateral plasma membrane vesicles were isolated from adult bovine type II pneumocytes. Uptakes of 22Na+ and [3H]glucose by enriched apical and basolateral vesicles were monitored over time. Following addition of external glucose (75 mM), 22Na+ uptake by mannitol-loaded, apically-enriched vesicles was significantly increased over controls. Substitution of interior-negative charge gradients for internally directed Na+ gradients increased glucose-dependent Na+ uptakes even greater. By contrast, external glucose did not significantly promote 22Na+ uptake by enriched basolateral vesicles. External Na+ (75 mM) significantly increased [3H]glucose uptakes by enriched apical vesicles with evidence of overshoot. Phlorizin (100 microM) inhibited both glucose-coupled 22Na+ uptakes and Na(+)-coupled [3H]glucose uptakes. These observations support localization of electrogenic, Na+/glucose cotransporters to enriched apical membranes of mature type II pneumocytes.